Three-dimensional (3D) printing has evolved as an emerging tool for the design of customized or personalized medication that provides the maximum therapeutic benefits to patients. The manufacturing of medicines in small batches customized with tailored dosages, sizes, shapes, and drug release properties is the key prospect of using 3D printing in pharmaceutics. Handbook of 3D Printing in Pharmaceutics: Innovations and Applications provides a detailed and in-depth technical discussion on the various additive manufacturing processes for the development of pharmaceutical products with experimental justification. It details the characterization, optimization, and numerical modeling of the processes involved and outlines the industrial implications of the resulting products as well as offering solutions for patient- tailored drugs processed by additive manufacturing. The handbook goes on to focus on the various post- processing technologies available to fortify the mechanical, chemical, biological, geometrical, and other characteristics of additively manufactured components and also discusses future directions and possible research gaps that need to be filled. The buyers of this cutting-edge handbook will learn the complete information and methodology for manufacturing drug delivery systems and customized medicine for biomedical applications. It is an ideal read for undergraduates, graduates, and postgraduate research scholars. Industrial and academic professionals working and studying industrial, manufacturing, and production engineering, along with those studying mechanical engineering, pharmaceutical sciences, material science, chemical engineering, biomedical engineering, automobile/aerospace engineering, and other relevant domains will want this handbook at their fingertips.

3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.

A Handbook of Artificial Intelligence in Drug Delivery explores the use of Artificial Intelligence (AI) in drug delivery strategies. The book covers pharmaceutical AI and drug discovery challenges, Artificial Intelligence tools for drug research, AI enabled intelligent drug delivery systems and next generation novel therapeutics, broad utility of AI for designing novel micro/nanosystems for drug delivery, AI driven personalized medicine and Gene therapy, 3D Organ printing and tissue engineering, Advanced nanosystems based on AI principles (nanorobots, nanomachines), opportunities and challenges using artificial intelligence in ADME/Tox in drug development, commercialization and regulatory perspectives, ethics in AI, and more. This book will be useful to academic and industrial researchers interested in drug delivery, chemical biology, computational chemistry, medicinal chemistry and bioinformatics. The massive time and costs investments in drug research and development necessitate application of more innovative techniques and smart strategies. - Focuses on the use of Artificial Intelligence in drug delivery strategies and future impacts - Provides insights into how artificial intelligence can be effectively used for the development of advanced drug delivery systems - Written by experts in the field of advanced drug delivery systems and digital health

Theoretical discussions covering granulation and engineering perspectives. Covers new advances in expert systems, process modelling and bioavailability Chapters on emerging technologies in particle engineering Updated Current research and developments in granulation technologies

This book presents a comprehensive and authoritative review of the recent developments and advances in biodegradable polymers and their biomedical applications. Following an interdisciplinary approach, it combines the medical and pharmaceutical fields in conjunction with biomedical engineering, polymer science, materials science, and pharmacological aspects of biodegradable polymers. The text covers the synthesis, properties, and characterization of biodegradable polymers and systems and their applications in sustained drug delivery, anticancer therapy, vaccine delivery, gene delivery, surgery, wound care, cardiology, dentistry, orthopedics, medical devices, tissue engineering, and cosmeceuticals. It also details the safety aspects, market economy, challenges, and opportunities related to biodegradable polymers, providing an understanding of the commercial and translational aspects of these crucial biomaterials. Edited and authored by renowned scientists working on biodegradable polymers, biocomposites, biodegradable systems, and implants, the book is an important resource for academicians, researchers, students, professionals, and general readers interested in exploring the potential biomedical applications of biodegradable polymers.

The 3D printing (3DP) process was patented in 1986; however, only in the last decade has it begun to be used for medical applications, as well as in the fields of prosthetics, bio-fabrication, and pharmaceutical printing. 3DP or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees of complexity with great reproducibility in a fast and cost-effective fashion. 3DP technology offers a new paradigm for the direct manufacture of individual dosage forms and has the potential to allow for variations in size and geometry as well as control dose and release behavior. Furthermore, the low cost and ease of use of 3DP systems means that the possibility of manufacturing medicines and medical devices at the point of dispensing or at the point of use could become a reality. 3DP thus offers the perfect innovative manufacturing route to address the critical capability gap that hinders the widespread exploitation of personalized medicines for molecules that are currently not easy to deliver. This Special Issue will address new developments in the area of 3D printing and bioprinting for drug delivery applications, covering the recent advantages and future directions of additive manufacturing for pharmaceutical products.

Printing is a process for reproducing text and image, typically with ink on paper using a printing press. It is often carried out as a large-scale industrial process, and is an essential part of publishing and transaction printing. Modern technology is radically changing the way publications are printed, inventoried and distributed. Printing technology market is growing, due to technological proliferation along with increasing applications of commercial printing across end users. In India, the market for printing technology is at its nascent stage; however offers huge growth opportunities in the coming years. The major factors boosting the growth of offset printing press market are the growth of packaging industry across the globe, increasing demand in graphic applications, the wide range of application in various industry, and industrialization. 3D printing market is estimated to garner $8.6 billion in coming years. The global digital printing packaging market is expected to exceed more than US$ 40.02 billion by 2026 at a CAGR of 13.9%. Computer-to-plate systems are increasingly being combined with all digital prepress and printing processes. This book is dedicated to the Printing Industry. In this book, the details of printing methods and applications are given. The book throws light on the materials required for the same and the various processes involved. This popular book has been organized to provide readers with a firmer grasp of how printing technologies are revolutionizing the industry. The major content of the book are principles of contact (impression), principles of noncontact printing, coated grades and commercial printing, tests for gravure printing, tests for letterpress printing, tests for offset printing, screen printing, application of screen printing, offset lithography, planography, materials, tools and equipments, sheetfed offset machines, web offset machines, colour and its reproduction, quality control in printing, flexography, rotogravure, creative frees printer, shaftless spearheads expansion, digital printing, 3D printing, 3D printing machinery, book binding, computer-to-plate (ctp) and photographs of machinery with suppliers contact details. A total guide to manufacturing and entrepreneurial success in one of today's most printing industry. This book is one-stop guide to one of the fastest growing sectors of the printing industry, where opportunities abound for manufacturers, retailers, and entrepreneurs. This is the only complete handbook on the commercial production of printing products. It serves up a feast of how-to information, from concept to purchasing equipment.

Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering explores the intricacies of nanostructures and 3D printed systems in terms of their design as drug delivery or tissue engineering devices, their further evaluations and diverse applications. The book highlights the most recent advances in both nanosystems and 3D-printed systems for both drug delivery and tissue engineering applications. It discusses the convergence of biofabrication with nanotechnology, constructing a directional customizable biomaterial arrangement for promoting tissue regeneration, combined with the potential for controlled bioactive delivery. These discussions provide a new viewpoint for both biomaterials scientists and pharmaceutical scientists. - Shows how nanotechnology and 3D printing are being used to create systems which are intelligent, biomimetic and customizable to the patient - Explores the current generation of nanostructured 3D printed medical devices - Assesses the major challenges of using 3D printed nanosystems for the manufacture of new pharmaceuticals